Compound K, a Ginsenoside Metabolite, Inhibits Colon Cancer Growth via Multiple Pathways Including p53-p21 Interactions
Zhiyu Zhang(Tianjin University of Science and Technology), Chun-Su Yuan(University of Chicago), Zejuan Li(University of Chicago), Eugene B. Chang(University of Chicago), Tyler Calway(University of Chicago), Tong‐Chuan He(Northwestern University), Wei Du(Nanjing Forestry University), Xiao-Dong Wen(University of Chicago), Chong-Zhi Wang(University of Chicago), Marc Bissonnette(University of Illinois Chicago), Guang-Jian Du(University of Chicago), Mark W. Musch(University of Chicago)
Cited by 92
Related Papers
Notch Signaling Augments BMP9-Induced Bone Formation by Promoting the Osteogenesis-Angiogenesis Coupling Process in Mesenchymal Stem Cells (MSCs)
|Cellular Physiology and Biochemistry|2017|2.8k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
|Regional Anesthesia & Pain Medicine|2009|1.5k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Is a p53-Regulated Inhibitor of G2/M Progression
|Molecular Cell|1997|1.2k